GC-MS determined cotinine in an epidemiological study on smoking status at delivery

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 3, 2008, Pages 485-488

  Chazeron, Ingrid de ^a   Daval, Sandrine ^a   Ughetto, Sylvie ^b   Richard, Damien ^a   Nicolay, Alain ^a   Lemery, Didier ^b   Llorca, Pierre M ^a   Coudoré, François ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b HÔTEL DIEU   (France)

Author keywords

Cotinine; Newborn; Pregnancy; Smoking status

Indexed keywords

COTININE;

ARTICLE; DELIVERY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; ION MONITORING; MASS FRAGMENTOGRAPHY; MATERNITY WARD; MOTHER; NEWBORN; PREGNANT WOMAN; PRIORITY JOURNAL; SMOKING;

ADULT; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COTININE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SMOKING;

EID: 43049174831     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.11.001     Document Type: Article

References (21)

1. Castles A., Adams E.K., Melvin C.L., Kelsch C., and Boulton M.L. Effects of smoking during pregnancy: five meta-analyses. Am J Prev Med 16 3 (1999) 208-215
2. Polanska K., and Hanke W. Influence of smoking during pregnancy on children's health-overview of epidemiologic studies. Przegl Epidemiol 59 1 (2005) 117-123
3. Blackford A.L., Yang G., Hernandez-Avila M., Przewozniak K., Zatonski W., Figueiredo V., et al. Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Cancer Epidemiol Biomarkers Prev 15 10 (2006) 1799-1804
4. Dhar P. Measuring tobacco smoke exposure: quantifying nicotine/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods. J Pharm Biomed Anal 35 1 (2004) 155-168
5. Diguet A., Sentilhes L., Marret S., Verspyck E., and Marpeau L. Neonatal management of a child exposed to tobacco in utero and postnatal biomarkers. J Gynecol Obstet Biol Reprod (Paris) 34 1:3 (2005) S458-S469
6. Niedbala R.S., Haley N., Kardos S., and Kardos K. Automated homogeneous immunoassay analysis of cotinine in urine. J Anal Toxicol 26 3 (2002) 166-170
7. Ghosheh O.A., Browne D., Rogers T., de Leon J., Dwoskin L.P., and Crooks P.A. A simple high performance liquid chromatographic method for the quantification of total cotinine, total 3′-hydroxycotinine and caffeine in the plasma of smokers. J Pharm Biomed Anal 23 2-3 (2000) 543-549
8. Stolker A.L., Niesing W., Hogendoorn E.A., Bisoen Rambali A., and Vleeming W. Determination of nicotine and cotinine in rat plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1020 1 (2003) 35-43
9. Cognard E., and Staub C. Determination of nicotine and its major metabolite cotinine in plasma or serum by gas chromatography-mass spectrometry using ion-trap detection. Clin Chem Lab Med 41 12 (2003) 1599-1607
10. Jacob III P., Wu S., Yu L., and Benowitz N.L. Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry. J Pharm Biomed Anal 23 4 (2000) 653-661
11. Jung B.H., Chung B.C., Chung S.J., Lee M.H., and Shim C.K. Simultaneous GC-MS determination of nicotine and cotinine in plasma for the pharmacokinetic characterization of nicotine in rats. J Pharm Biomed Anal 20 1-2 (1999) 195-202
12. Man C.N., Gam L.H., Ismail S., Lajis R., and Awang R. Simple, rapid and sensitive assay method for simultaneous quantification of urinary nicotine and cotinine using gas chromatography-mass spectrometry. J Chromatogr B-Anal Technol Biomed Life Sci 844 2 (2006) 322-327
13. Shin H.S., Kim J.G., Shin Y.J., and Jee S.H. Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography-mass spectrometry. J Chromatogr B-Anal Technol Biomed Life Sci 769 1 (2002) 177-183
14. Torano J.S., and van Kan H.J. Simultaneous determination of the tobacco smoke uptake parameters nicotine, cotinine and thiocyanate in urine, saliva and hair, using gas chromatography-mass spectrometry for characterisation of smoking status of recently exposed subjects. Analyst 128 7 (2003) 838-843
15. Gunter E.W. Biological and environmental specimen banking at the Centers for Disease Control and Prevention. Chemosphere 34 9-10 (1997) 1945-1953
16. McDonald S.D., Perkins S.L., and Walker M.C. Correlation between self-reported smoking status and serum cotinine during pregnancy. Addict Behav 30 4 (2005) 853-857
17. Hanke W., Sobala W., and Kalinka J. Environmental tobacco smoke exposure among pregnant women: impact on fetal biometry at 20-24 weeks of gestation and newborn child's birth weight. Int Arch Occup Environ Health 77 1 (2004) 47-52
18. Tobacco smoking and pregnancy. Rev Mal Respir 2005;22(1, Part 1):185-8.
19. Twardella D., Kupper-Nybelen J., Rothenbacher D., Hahmann H., Wusten B., and Brenner H. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Eur Heart J 25 23 (2004) 2101-2108
20. Bernert Jr. J.T., McGuffey J.E., Morrison M.A., and Pirkle J.L. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal Toxicol 24 5 (2000) 333-339
21. Vartiainen E., Seppala T., Lillsunde P., and Puska P. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health 56 3 (2002) 167-170